Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports

Analysis of the brain specific biomarkers amyloid β(42) (Aβ(42)) and total tau (t-tau) protein in cerebrospinal fluid (CSF) has a sensitivity and specificity of more than 85% for differentiating Alzheimer's Disease (AD) from non-demented controls. International guidelines are contradictory in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Slats, Diane, Spies, Petra E., Sjögren, Magnus J.C., Verhey, Frans R.J., Verbeek, Marcel M., Olde Rikkert, Marcel G.M.
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: February 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914365/
https://www.ncbi.nlm.nih.gov/pubmed/20689628
http://dx.doi.org/10.1159/000286280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914365/
https://www.ncbi.nlm.nih.gov/pubmed/20689628
http://dx.doi.org/10.1159/000286280

Ejemplares similares